Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China To Awaken RMB 100 Billion Pharma Giant In 2011-15

This article was originally published in PharmAsia News

Executive Summary

China's 12 Five Year Plan for the pharmaceutical industry, to be unveiled after the annual sessions of NPC and CPPCC, will center on encouraging mergers and acquisitions in the industry, aiming to have one to two RMB 100 billion-scale national pharmaceutical giants and 20 RMB 10 billion regional drug giants by 2015, Vice Commerce Minister Jiang Zengwei revealed at the CPPCC annual session March 10
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC077378

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel